SEC Form 4 · accession 0001385508-18-000091
OPIANT PHARMACEUTICALS, INC. · OPNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger Crystal
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Oct 5, 2018
Accepted (ET)
Oct 10, 2018 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385508
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 5, 2018 | S | 847 | $18.14 | D | 18,475 | D | |
| Common StockF1 | Oct 8, 2018 | S | 3,059 | $17.33 | D | 15,416 | D | |
| Common StockF1 | Oct 9, 2018 | S | 6,941 | $17.04 | D | 8,475 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.